Cumberland Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Cumberland Pharmaceuticals

12/05/2021 24:39

* Cumberland Pharmaceuticals Inc  CPIX.OQ  reported quarterly
adjusted earnings of 7 cents​​ per share for the quarter ended
in March. The lone analyst forecast for the quarter was for a
loss of 7 cents per share.
* Revenue rose 26.5% to $10.54 million from a year ago; 
analysts expected $8.50 million. 
* Cumberland Pharmaceuticals Inc's reported EPS for the quarter
was 1 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Cumberland Pharmaceuticals Inc shares had fallen by 12.5% this
quarter and lost 10.2% so far this year.
* The company reported quarterly net income of $167 thousand.
* Wall Street's median 12-month price target for Cumberland
Pharmaceuticals Inc is $8.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 11 at 11:39 p.m. GMT.
​All figures in US dollars